Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-54.49	33.25	73.05
Graham Fair Price	68.70	15.35	9.10
PEG	-90.74	0.07	-0.76
Price/Book	0.92	2.75	2.72
Price/Cash Flow	-77.22	63.70	-279.63
Prices/Earnings	-68.77	14.04	44.95
Price/Sales	-22.11	5.45	7.00
Price/FCF	-77.22	63.70	-279.63
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	48.10	0.18	0.12
Operating Margin	135.87	0.14	0.06
ROA	215.16	0.03	< 0.005
ROE	0.02	0.05	223.12
ROIC	0.01	0.04	203.51
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.19	0.24	-22.57
Dividends QOQ	0.01	0.21	1665.17
EBIT QOQ	-0.59	1.80	204.38
EPS QOQ	-0.59	2.00	237.14
FCF QOQ	-1.28	5.06	296.22
Revenue QOQ	-0.14	0.19	29.10
Naive Interpretation	member

03 - Financial Growth · Best

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	17.47	12.86	-26.42
Days Sales Outstanding (DSO)	10.22	2.25	-77.96
Inventory Turnover	5.15	7.00	35.90
Debt/Capitalization	0.28	0.26	-8.51
Quick Ratio	1.19	1.09	-8.34
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	15.58	14.63	-6.15
Cash	6.33	5.97	-5.59
Capex	-0.52	-0.47	8.50
Free Cash Flow	-0.15	0.63	315.80
Revenue	6.07	7.38	21.61
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.42	1.39	-1.58
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	5.46	2.26	-58.69
Naive Interpretation	Member

06 - Financial Health · Weak

Rating